Access to Medicines – Page 26

EPHA’s response to the EU Ombudsman consultation on the EMA’s pre-submission activities

by European Public Health Alliance | Jan 31, 2019 | Consultation Responses

Click on the button below to read EPHA’s response to the public consultation “How the European Medicines Agency engages with medicine producers before they apply for authorisations to market their medicines in the EU – Invitation to comment within the...

Access to research & innovation at risk in the next EU research programme

by European Public Health Alliance | Dec 13, 2018 | Statements

Civil society reaction to the European Parliament’s position on Horizon Europe 12 DEC. The European Commission’s original proposal for Horizon Europe failed to include concrete measures that would help to maximise public return on investments for publicly funded...

EPHA Joins Call for Public Return on Public Investment: Ensuring sustainable societal impact of EU-funded Biomedical Research and Innovation

by EPHA | Oct 4, 2018 | Consultation Responses

Civil society’s proposal for Horizon Europe, the next EU research framework programme High prices of new drugs for cancer, hepatitis C and rare diseases in Europe have attracted great media and public attention and have brought the debate about access to medicines...

How good are our medicines?

by EPHA | Aug 27, 2018

How good are our medicines? An operational agenda for EU & national policy-makers  3 October 2018  14:45 - 17:15 CEST  Bad Hofgastein Organised by Open Society Foundations (OSF) in cooperation with the European Alliance for Responsible R&D and Affordable...

Getting it right: EPHA recommendations on how to improve the European Commission proposal on Health Technology Assessment (HTA)

by European Public Health Alliance | Jul 11, 2018 | Position & Policy Papers

EPHA welcomes the European Commission proposal for a Regulation on Health Technology Assessment (HTA), amending Directive 2011/24/EU. We believe strongly in Health Technology Assessment as a powerful ally of patients and healthcare systems. Our recommendations aim to...